Floatz logo

Byetta

Diabetes Mellitus

Assistance Publique Hopitaux De MarseilleUNKNOWNPhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
81/ 100

Competitive context

43 Active assets in the Diabetes Mellitus cohort.

Asset / SponsorPhaseRating
Metformin
Erbil Polytechnic University
Phase 4A
Pioglitazone
Milton S. Hershey Medical Center
Phase 4BBB
Alogliptin
Takeda
Phase 3BBB
Glibenclamide
Takeda
Phase 4BBB
Aspirin
Region Skane
Phase 4BBB

View all 49 →

Same molecule, other indications

Byetta is also rated in:

polycystic ovary syndromeDormant
B
Indicative · Phase 2/3
61 / 100
View asset →
obesity disorderDormant
B
Indicative · Phase 3
60 / 100
View asset →
fatty liver diseaseDormant
B
Indicative · Phase 2/3
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →